Universal Technical Institute IncNYSE: UTI

Financial Supplement (Q4 2026 Financial Supplement)

· Issued by Universal Technical Institute Inc

UNIVERSAL TECHNICAL INSTITUTE, INC.

Q4 FY2026 FINANCIAL SUPPLEMENT

Consolidated Q4 2026 Highlights

$235.9 million $897.0 million

$18.0 million $33.6 million

$42.5 million $102.0 million

$0.32 $0.60

Note: See Company Press Release and Investor Presentation dated November 18, 2026 for more details on guidance, including non-GAAP reconciliations.

Revenue increased 6.0% to $235.9 million. The Concorde division contributed $82.2 million (5.7% YoY), and the UTI division contributed $153.6 million (6.2% YoY growth).

Revenue

Revenue

FY 2026

Q4 2026

Total Full-Time Active Students grew 6.3% year-over-year to 26,630.

Net Income Net Income

Net Income was $18.0 million or $0.32 per diluted share.

Adjusted EBITDA Adjusted EBITDA

Baseline adjusted EBITDA was $49.5 million. Including $7.0 million in net growth investments, reported adjusted EBITDA was $42.5 million.

Diluted Earnings Per Diluted Earnings Per

Share Share

Total available liquidity of $320.8 million, including cash, cash equivalents, and remaining capacity on our revolving credit facility-ample reserves for any potential working capital needs or new opportunities that may arise for the Company.

The Company concluded the fiscal year well-positioned and remains confident in delivering its 5-year strategic targets of over $1.2 billion in Revenue and Adjusted EBITDA approaching $220M by FY2029.

Consolidated Q4 2026 Summary Results

($ in millions)

3 Mos. 9/30/26

3 Mos. 9/30/25

YoY Change

12 Mos. 9/30/26

12 Mos. 9/30/25

YoY Change

Revenues

$235.9

$222.4

6.0%

$897.0

$835.6

7.4%

Operating expenses

$209.6

$197.5

6.2%

$851.5

$752.1

13.2%

Educational services and facilities

$124.1

$112.3

10.5%

$470.3

$420.5

11.8%

Selling, general and administrative

$85.5

$85.2

0.4%

$381.2

$331.7

14.9%

Income from operations

$26.3

$25.0

5.1%

$45.5

$83.5

(45.4)%

Total other (expense) income, net

$(0.2)

$0.6

(130.0)%

$0.3

$0.8

(68.8)%

Income tax expense

$(8.1)

$(6.8)

18.4%

$(12.2)

$(21.3)

(42.6)%

Net income

$18.0

$18.8

(3.8)%

$33.6

$63.0

(46.7)%

Adjusted EBITDA(1)

$42.5

$36.8

15.5%

$102.0

$126.5

(19.3)%

Operating cash flow

$76.8

$57.1

34.5%

$94.2

$97.3

(3.2)%

Adjusted free cash flow(1)

$53.0

$41.0

29.2%

$(12.6)

$56.0

(122.5)%

Purchase of property and equipment

$25.5

$16.5

54.9%

$106.4

$42.0

153.5%

Capitalized costs for intangible assets

$2.0

$-

-%

$6.5

$-

-%

1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18.

Consolidated Statements of Operations Trend

($ in thousands, except EPS)

12 Mos. 9/30/26

3 Mos. 9/30/26

3 Mos. 6/30/26

3 Mos. 3/31/26

3 Mos. 12/31/25

12 Mos. 9/30/25

3 Mos. 9/30/25

3 Mos. 6/30/25

3 Mos. 3/31/25

3 Mos. 12/31/24

Revenues

$ 897,036

$ 235,883

$ 218,907

$ 221,402

$ 220,844

$ 835,616

$ 222,442

$ 204,298

$ 207,447

$ 201,429

Operating expenses:

Educational services and facilities

470,295

124,084

118,334

117,429

110,448

420,491

112,258

105,604

102,488

100,141

Selling, general and administrative

381,205

85,534 97,328 103,634 94,709

331,656

85,198 84,542 88,106 73,810

Total operating expenses

851,500

209,618 215,662 221,063 205,157

752,147

197,456 190,146 190,594 173,951

Income from operations

45,536

26,265

3,245

339

15,687

83,469

24,986

14,152

16,853

27,478

Total other (expense) income, net

251

(172)

(146)

44

525

805

573

200

(19)

51

Income tax (expense) benefit

(12,211)

(8,056) (820) 50 (3,385)

(21,256)

(6,803) (3,689) (5,388) (5,376)

Net Income

33,576

18,037 2,279 433 12,827

63,018

18,756 10,663 11,446 22,153

Net income per share, diluted

$ 0.60

$ 0.32

$ 0.04

$ 0.01

$ 0.23

$ 1.13

$ 0.34

$ 0.19

$ 0.21

$ 0.40

EBITDA(1)

$ 86,025

$ 38,362

$ 13,758

$ 9,361

$ 24,542

$ 116,692

$ 33,634

$ 22,616

$ 25,000

$ 35,442

Total Shares Outstanding (Period End)

55,099

55,099

55,095

55,061

55,014

54,430

54,430

54,424

54,406

54,366

Weighted Average Diluted Shares Outstanding

55,802

55,808

55,935

55,730

55,744

55,615

55,728

55,635

55,442

55,406

  1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18.

    Consolidated Results of Operations Trend Percent of Revenue

    12 Mos.

    9/30/26

    3 Mos.

    9/30/26

    3 Mos.

    6/30/26

    3 Mos.

    3/31/26

    3 Mos.

    12/31/25

    12 Mos.

    9/30/25

    3 Mos.

    9/30/25

    3 Mos.

    6/30/25

    3 Mos.

    3/31/25

    3 Mos.

    12/31/24

    Revenues

    100.0%

    100.0%

    100.0%

    100.0%

    100.0%

    100.0%

    100.0%

    100.0%

    100.0%

    100.0%

    Operating Expenses:

    Educational services and facilities

    52.4%

    52.6%

    54.1%

    53.0%

    50.0%

    50.3%

    50.5%

    51.7%

    49.4%

    49.8%

    Selling, general and administrative

    42.5%

    36.3%

    44.5%

    46.8%

    42.9%

    39.7%

    38.3%

    41.4%

    42.5%

    36.6%

    Total operating expenses

    94.9%

    88.9%

    98.6%

    99.8%

    92.9%

    90.0%

    88.8%

    93.1%

    91.9%

    86.4%

    Income from operations

    5.1%

    11.1%

    1.5%

    0.2%

    7.1%

    10.0%

    11.2%

    6.9%

    8.1%

    13.6%

    Total other (expense) income, net

    -%

    (0.1)%

    (0.2)%

    -%

    0.2%

    0.1%

    0.3%

    0.1%

    -%

    0.1%

    Income tax (expense) benefit

    (1.4)%

    (3.4)%

    (0.4)%

    0.0%

    (1.5)%

    (2.5)%

    (3.1)%

    (1.8)%

    (2.6)%

    (2.7)%

    Net Income

    3.7%

    7.6%

    1.0%

    0.2%

    5.8%

    7.6%

    8.4%

    5.2%

    5.5%

    11.0%

    EBITDA(1)

    9.6%

    16.3%

    6.3%

    4.2%

    11.1%

    14.0%

    15.1%

    11.1%

    12.1%

    17.6%

    1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18.

Quarterly Trend - Segment Key Metrics

($ in millions, except revenue per student amounts)

3 Mos. 9/30/26

UTI

3 Mos. 6/30/26

UTI

3 Mos. 3/31/26

UTI

3 Mos. 12/31/25

UTI

3 Mos. 9/30/25

UTI

3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 9/30/26 6/30/26 3/31/26 12/31/25 9/30/25

Concorde Concorde Concorde Concorde Concorde

New student starts

7,339

3,491

4,110

2,893

7,166

5,174

2,851

3,459

2,556

4,943

Y/Y growth/(decline)

2.4%

23.4%

14.5%

5.1%

1.4%

4.7%

(1.4)%

13.1%

(0.2)%

11.7%

Average full-time active students

15,988

14,767

15,556

16,347

15,207

10,642

10,364

10,829

10,511

9,842

Y/Y growth/(decline)

5.1%

4.0%

5.3%

5.7%

8.1%

8.1%

8.5%

10.2%

9.5%

8.0%

Revenue per student

$9,600

$9,300

$9,200

$8,700

$9,500

$7,700

$7,800

$7,300

$7,400

$7,900

Y/Y growth/(decline)

1.1%

0.0%

1.1%

2.4%

2.2%

(2.5)%

2.6%

(1.4)%

1.4%

9.7%

Revenues

$153.6

$138.0

$142.7

$142.8

$144.6

$82.2

$80.9

$78.7

$78.0

$77.8

Y/Y growth/(decline)

6.2%

4.9%

6.3%

8.6%

10.8%

5.7%

11.1%

7.5%

11.4%

18.2%

Income from operations

$38.2

$22.6

$22.8

$33.1

$39.6

$12.2

$13.0

$10.1

$13.3

$13.3

Margin

24.9%

16.4%

16.0%

23.2%

27.4%

14.8%

16.1%

12.8%

17.1%

17.1%

Adjusted EBITDA(1)

$32.4

$14.3

$11.3

$22.7

$30.9

$8.5

$6.4

$2.2

$6.2

$7.3

Adjusted EBITDA margin

21.1%

10.3%

7.9%

15.9%

21.4%

10.3%

7.9%

2.7%

7.9%

9.4%

1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18.

Segment Results of Operations: Fourth Quarter

($ in thousands)

3 Mos.

3 Mos.

3 Mos.

3 Mos.

3 Mos.

3 Mos.

9/30/26

9/30/26

9/30/26

9/30/25

9/30/25

9/30/25

UTI

Concorde

Total

UTI

Concorde

Total

Revenues

$ 153,648

$ 82,235

$ 235,883

$ 144,648

$ 77,794

$ 222,442

Compensation and benefits

54,300

35,077

89,377

51,907

33,849

85,756

Advertising

14,602

8,999

23,601

12,718

7,784

20,502

Occupancy

11,414

6,910

18,324

11,621

6,563

18,184

Student related

17,149

7,721

24,870

11,734

7,074

18,808

General operations

6,336

5,994

12,330

6,723

4,934

11,657

Professional and contract services

2,181

1,039

3,220

2,536

1,330

3,866

Depreciation and amortization

8,199

3,476

11,675

6,138

2,055

8,193

Other expenses

1,228

797

2,025

1,646

887

2,533

Total operating expenses

$ 115,409

$ 70,013

$ 185,422

$ 105,023

$ 64,476

$ 169,499

Corporate costs

-

-

24,196

-

-

27,957

Income from operations

38,239

12,222

26,265

39,625

13,318

24,986

Net income

23,665

4,765

18,037

23,418

5,000

18,756

EBITDA(1)

32,663

8,283

38,362

30,374

7,068

33,634

Adjusted EBITDA(1)

32,446

8,536

42,490

30,856

7,301

36,779

Adjusted EBITDA margin

21.1%

10.4%

18.0%

21.3%

9.4%

16.5%

1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18.

Segment Results of Operations: Year-to-Date

($ in thousands)

12 Mos.

12 Mos.

12 Mos.

12 Mos.

12 Mos.

12 Mos.

9/30/26

9/30/26

9/30/26

9/30/25

9/30/25

9/30/25

UTI

Concorde

Total

UTI

Concorde

Total

Revenues

$ 577,225

$ 319,811

$ 897,036

$ 541,815

$ 293,801

$ 835,616

Compensation and benefits

224,003

144,726

368,729

205,031

131,978

337,009

Advertising

67,815

37,988

105,803

57,754

30,575

88,329

Occupancy

43,449

26,165

69,614

39,866

24,769

64,635

Student related

51,797

24,309

76,106

38,245

24,084

62,329

General operations

28,153

19,527

47,680

20,702

17,919

38,621

Professional and contract services

9,697

4,895

14,592

9,866

5,198

15,064

Depreciation and amortization

28,525

10,468

38,993

24,086

7,554

31,640

Other expenses

7,089

3,142

10,231

6,504

3,665

10,169

Total operating expenses

$ 460,528

$ 271,220

$ 731,748

$ 402,054

$ 245,742

$ 647,796

Corporate costs

-

-

119,752

-

-

104,351

Income from operations

116,697

48,591

45,536

139,761

48,059

83,469

Net income

47,087

11,447

33,576

77,731

16,593

63,018

EBITDA(1)

78,837

22,036

86,025

106,379

24,274

116,692

Adjusted EBITDA(1)

80,786

23,266

102,031

108,274

24,983

126,455

Adjusted EBITDA margin

14.0%

7.3%

11.4%

20.0%

8.5%

15.1%

1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18.

Consolidated Balance Sheet and Cash Flow Summary

($ in thousands)

127,361

144,212 $

$

Cash & cash equivalents

9/30/25

9/30/26

At:

97,330

94,232 $

$

Net cash provided by operating activities

12 Mos.

9/30/25

12 Mos.

9/30/26

Short-term investments

26,570

41,784

Purchase of property and equipment

(106,429)

(41,978)

Total current assets

253,035

246,632

Capitalized costs for intangible assets

(6,514)

-

PP&E (net)

357,154

285,852

Purchase of investments

(57,347)

(68,371)

Goodwill and Intangible assets, net 55,248 45,811

Right-of-use assets for operating leases

188,005

178,861

Notes receivable, less current portion 47,484 41,109 Total assets 923,478 826,139

Long term debt, current portion 3,039 2,865

Operating lease liability, current portion 17,524 16,967 Total current liabilities 232,668 229,671

Net cash used in investing activities (93,916) (87,879)

Proceeds from sale of investments

31,668

-

Proceeds received upon maturity of investments

44,670

22,301

Proceeds from revolving credit facilities 245,000 26,000 Payments on revolving credit facilities (215,000) (62,000) Payment of term loans and finance leases (2,865) (2,697)

Payment of payroll taxes on stock-based compensation through shares withheld

(8,772)

(4,755)

Operating lease liability

192,848

174,838

Long-term debt

111,287

84,234

Change in cash and restricted cash

18,679

(33,342)

Total liabilities

559,337

498,029

Ending balance of cash and restricted cash

$ 152,809

$ 134,130

Stockholders' equity

364,141

328,110

Total liabilities & equity

$ 923,478

$ 826,139

Net cash provided by (used in) financing activities 18,363 (42,793)

Earnings Per Share Trend and Guidance

($ in thousands, except EPS)

Guidance

Fiscal 2027 Midpoint

Actual

12 Mos. 9/30/26

Actual

3 Mos. 9/30/26

Actual

3 Mos. 6/30/26

Actual

3 Mos. 3/31/26

Actual

3 Mos. 12/31/25

Actual

12 Mos. 9/30/25

Actual

3 Mos. 9/30/25

Actual

3 Mos. 6/30/25

Actual

3 Mos. 3/31/25

Actual

3 Mos. 12/31/24

Net Income

~$0-5,000

$ 33,576

$ 18,037

$ 2,279

$ 433

$ 12,827

$ 63,018

$ 18,756

$ 10,663

$ 11,446

$ 22,153

Weighted average basic shares outstanding

~55,400

54,943

55,096

55,075

55,033

54,570

54,301

54,425

54,412

54,383

53,987

Basic income per common share

~$0.00-0.09

$ 0.61

$ 0.33

$ 0.04

$ 0.01

$ 0.24

$ 1.16

$ 0.34

$ 0.20

$ 0.21

$ 0.41

Weighted average basic shares outstanding

~55,400

54,943

55,096

55,075

55,033

54,570

54,301

54,425

54,412

54,383

53,987

Dilutive effect related to employee stock plans

~900

859

712

860

697

1,175

1,314

1,303

1,223

1,059

1,419

Weighted average diluted shares outstanding

~56,300

55,802

55,808

55,935

55,730

55,745

55,615

55,728

55,635

55,442

55,406

Diluted income per common share

~$0.00-0.09

$ 0.60

$ 0.32

$ 0.04

$ 0.01

$ 0.23

$ 1.13

$ 0.34

$ 0.19

$ 0.21

$ 0.40

Term Loan: Avondale Campus

Debt as of 09/30/2026

Leverage Ratios

LTM EBITDA $102.0M

Original Note Amount $31.2M

Inception Date 5/12/2021

$114.3M

Total Debt, net

Leverage as of 09/30/2026

Rate* Fixed/Floating

Maturity 7 years

1.12x

(0.55)x

Gross Leverage Ratio

Net Leverage Ratio

$170.8M

Cash, Cash Equivalents, and Short-Term Investments

Current Note Balance $26.6M

Term Loan: Lisle Campus

Original Note Amount $38.0M

LTM EBITDA - FY 2027 Guidance Midpoint ~$103M

Inception Date 4/14/2022

Rate** Fixed/Floating

~$111M

Total Debt, net (Projected)

Proforma Leverage 09/30/2027

Current Note Balance $35.1M

Maturity 7 years

Revolving Credit Facility

~1.08x

~(0.57)x

Gross Leverage Ratio

Net Leverage Ratio

Cash, Cash Equivalents, and Short-Term Investments (Projected) ~$170M

Total Capacity $200.0M

Inception Date 8/12/2026

9/30/2027 proforma leverage calculation is based upon midpoint of the adjusted EBITDA guidance range and projected year-end cash balance, both of which will depend on actual company performance. For a detailed reconciliation of Non-GAAP measures, see slides 14-18.

Note: Use of the revolver will continue to be evaluated throughout the year and used as needed to support working capital needs and satisfy regulatory requirements &/or debt covenants. Any change to the outstanding revolver balance would affect gross leverage but have no impact on net leverage.

Rate*** Floating

Maturity 5 years

Current Loan Balance $50.0M

*Avondale rate is 50% fixed at 1.45% + 50% Floating @ SOFR plus 2% Margin and a tranche adjustment of 0.046%

**Lisle rate is 50% fixed at 4.69% + 50% Floating @ SOFR plus 2% Margin

***Revolver rate is term SOFR plus 1.50% to 2.25% margin based on UTI's total leverage

Use of Non-GAAP Financial Information

In addition to disclosing financial results that are determined in accordance with U.S. generally accepted accounting principles ("GAAP"), the Company also discloses certain non-GAAP financial information in this press release and may similarly disclose non-GAAP financial information on the related conference call. These financial measures are not recognized measures under GAAP and are not intended to be and should not be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. The Company discloses these non-GAAP financial measures because it believes that they provide investors an additional analytical tool to clarify its results of operations and identify underlying trends. Additionally, the Company believes that these measures may also help investors compare its performance on a consistent basis across time periods. Additional details on our non-GAAP measures and the tables reconciling these measures to the most directly comparable GAAP measure are provided below.

Management utilizes adjusted figures as performance measures internally for operating decisions, strategic planning, annual budgeting and forecasting. For the periods presented, our adjustments for items that management does not consider to be normal recurring operations include:

  • Acquisition-related costs: We have excluded costs associated with both potential and announced acquisitions to allow for comparable financial results to historical operations and forward-looking guidance.

  • Integration-related costs for completed acquisitions: We have excluded integration costs related to business structure realignment and new programs for recent acquisitions to allow for comparable financial results to historical operations and forward-looking guidance. In addition, the nature and amount of such charges vary significantly based on the size and timing of the programs. By excluding the referenced expenses from our non-GAAP financial measures, our management is able to further evaluate our ability to utilize existing assets and estimate their long-term value. Furthermore, our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.

  • Restructuring costs: In May 2026, management approved and implemented phase I of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. Phase II was rolled out in July 2026 and is expected to span over the next three years as part of our continued focus on optimization and to better align resources to support our overall growth strategy. In December 2023, we announced plans to consolidate the two Houston, Texas campus locations to align the curriculum, student facing systems, and support services to better serve students seeking careers in in-demand fields. As part of the transition, the MIAT Houston campus began a phased teach-out in May 2024 and began operating under the UTI brand.

    To obtain a complete understanding of our performance, these measures should be examined in connection with net income (loss) and net cash provided by (used in) operating activities, determined in accordance with GAAP, as presented in the financial statements and notes thereto included in the annual and quarterly filings with the Securities and Exchange Commission ("SEC"). Because the items excluded from these non-GAAP measures are significant components in understanding and assessing our financial performance under GAAP, these measures should not be considered to be an alternative to net income (loss) or net cash provided by (used in) operating activities as a measure of our operating performance or liquidity. Exclusion of items in the non-GAAP presentation should not be construed as an inference that these items are unusual, infrequent or non-recurring. Other companies, including other companies in the education industry, may define and calculate non-GAAP financial measures differently than we do, limiting their usefulness as a comparative measure across similarly titled performance measures presented by other companies. A reconciliation of the historical non-GAAP financial measures to the most directly comparable GAAP measures is provided below and investors are encouraged to review the reconciliations.

    Information reconciling forward-looking adjusted EBITDA and adjusted free cash flow to the most directly comparable GAAP financial measure is unavailable to the company without unreasonable effort. The company is not able to provide a quantitative reconciliation of forward-looking adjusted EBITDA or adjusted free cash flow to the most directly comparable GAAP financial measure because certain items required for such reconciliation are uncertain, outside of the company's control and/or cannot be reasonably predicted, including but not limited to the provision for (benefit from) income taxes. Preparation of such reconciliation would require a forward-looking statement of income and statement of cash flows prepared in accordance with GAAP, and such forward-looking financial statements are unavailable to the company without unreasonable effort.

    Consolidated Adjusted EBITDA Reconciliation

    ($ in thousands)

    QUARTER-TO-DATE 12 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 12 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 9/30/26 9/30/26 6/30/26 3/31/26 12/31/25 9/30/25 9/30/25 6/30/25 3/31/25 12/31/24

    Net income, as reported

    $ 33,576

    $ 18,037 $ 2,279 $ 433 $ 12,827

    $ 63,018

    $ 18,756 $ 10,663 $ 11,446 $ 22,153

    Interest (income) expense, net

    (166)

    227 249 (67) (575)

    (540)

    (431) (51) 28 (86)

    Income tax expense (benefit)

    12,211

    8,056 820 (50) 3,385

    21,256

    6,803 3,689 5,388 5,376

    Depreciation and amortization

    40,404

    12,042 10,410 9,045 8,905

    32,958

    8,506 8,315 8,138 7,999

    EBITDA $ 86,025 $ 38,362 $ 13,758 $ 9,361 $ 24,542 $ 116,692 $ 33,634 $ 22,616 $ 25,000 $ 35,442

    Stock-based compensation expense

    11,105

    1,679 2,970 3,901 2,555

    9,151

    2,749 2,658 3,024 720

    Restructuring costs(1)

    2,800

    1,704 1,096 - -

    43

    - - - 43

    Integration related costs for completed acquisitions(2)

    2,101

    745 421 884 51

    (304)

    396 - - (700)

    Acquisition related costs(3)

    -

    - - - -

    873

    - - 873 -

    Adjusted EBITDA, non-GAAP $ 102,031 $ 42,490 $ 18,245 $ 14,146 $ 27,148 $ 126,455 $ 36,779 $ 25,274 $ 28,897 $ 35,505

    1. In May 2026 and July 2026, management approved and implemented phase I and II of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025.

    2. In fiscal 2025, the Company received $0.7 million in funds in final settlement of the outstanding escrow accounts affiliated with the purchase of Concorde on December 1, 2022. This is offset by additional integration costs incurred during the year.

    3. Costs related to both announced and potential acquisition targets.

Consolidated Adjusted EBITDA Reconciliation

($ in thousands)

YEAR-TO-DATE

12 Mos. 9/30/26

9 Mos. 6/30/26

6 Mos. 3 Mos. 12 Mos. 9 Mos. 6 Mos. 3 Mos. 3/31/26 12/31/25 9/30/25 6/30/25 3/31/25 12/31/24

Net income, as reported

$ 33,576

$ 15,539 $ 13,260 $

12,827

$ 63,018

$ 44,262 $ 33,599 $

22,153

Interest (income) expense, net

(166)

(393) (642)

(575)

(540)

(109) (58)

(86)

Income tax expense

12,211

4,155 3,335

3,385

21,256

14,453 10,764

5,376

Depreciation and amortization

40,404

28,361 17,950

8,905

32,958

24,452 16,137

7,999

EBITDA

$ 86,025 $ 47,662 $ 33,903 $

24,542 $ 116,692 $ 83,058 $ 60,442 $

35,442

Stock-based compensation expense

11,105

9,426 6,456

2,555

9,151

6,402 3,744

720

Restructuring costs(1)

2,800

1,096

-

-

43

43 43

43

Integration related costs for completed acquisitions(2)

2,101

1,356

935

51

(304)

(700) (700)

(700)

Acquisition related costs(3)

-

-

-

-

873

873 873

-

Adjusted EBITDA, non-GAAP

$ 102,031 $

59,540 $

41,294 $

27,148 $ 126,455 $ 89,676 $ 64,402 $

35,505

  1. In May 2026 and July 2026, management approved and implemented phase I and II of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025.

  2. In fiscal 2025, the Company received $0.7 million in funds in final settlement of the outstanding escrow accounts affiliated with the purchase of Concorde on December 1, 2022. This is offset by additional integration costs incurred during the year.

  3. Costs related to both announced and potential acquisition targets.

    Adjusted EBITDA Reconciliation By Segment

    ($ in thousands)

    QUARTER-TO-DATE 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 9/30/26 9/30/25 9/30/26 9/30/25 9/30/26 9/30/25

    UTI UTI Concorde Concorde Corporate Corporate

    Net income (loss), as reported

    $ 23,665 $

    23,418 $

    4,765 $

    5,000 $

    (10,393) $

    (9,662)

    Interest expense (income), net

    799

    797

    42

    13

    (614)

    (1,241)

    Income tax expense

    -

    -

    -

    -

    8,056

    6,803

    Depreciation and amortization

    8,199

    6,159

    3,476

    2,055

    367

    292

    EBITDA

    $ 32,663

    $ 30,374

    $ 8,283

    $ 7,068

    $ (2,584) $

    (3,808)

    Stock-based compensation expense

    (217)

    482

    253

    233

    1,643

    2,034

    Restructuring costs(1)

    -

    -

    -

    -

    1,704

    -

    Integration related costs for completed acquisitions

    -

    -

    -

    -

    745

    396

    Adjusted EBITDA, non-GAAP

    $ 32,446

    $ 30,856

    $ 8,536

    $ 7,301

    $ 1,508 $

    (1,378)

    1. In May 2026 and July 2026, management approved and implemented phase I and II of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025.

Adjusted EBITDA Reconciliation By Segment

($ in thousands)

YEAR-TO-DATE

12 Mos. 9/30/26

12 Mos. 9/30/25

12 Mos. 9/30/26

12 Mos. 9/30/25

12 Mos. 9/30/26

12 Mos. 9/30/25

UTI UTI Concorde Concorde Corporate Corporate

Net income (loss), as reported

$ 47,087 $

77,731 $

11,447 $

16,593 $

(24,958) $

(31,306)

Interest expense (income), net

3,225

4,479

121

127

(3,512)

(5,146)

Income tax expense

-

-

-

-

12,211

21,256

Depreciation and amortization

28,525

24,169

10,468

7,554

1,411

1,235

EBITDA

$ 78,837

$ 106,379

$ 22,036

$ 24,274

$ (14,848) $

(13,961)

Stock-based compensation expense

1,237

1,852

1,000

709

8,868

6,590

Restructuring costs(1)

712

43

230

-

1,858

-

Integration related costs for completed acquisitions(2)

-

-

-

-

2,101

(304)

Acquisition related costs(3)

-

-

-

-

-

873

Adjusted EBITDA, non-GAAP

$ 80,786

$ 108,274

$ 23,266

$ 24,983

$ (2,021) $

(6,802)

  1. In May 2026 and July 2026, management approved and implemented phase I and II of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025.

  2. In fiscal 2025, the Company received $0.7 million in funds in final settlement of the outstanding escrow accounts affiliated with the purchase of Concorde on December 1, 2022. This is offset by additional integration costs incurred during the year.

  3. Costs related to both announced and potential acquisition targets.

Consolidated Adjusted Free Cash Flow

($ in thousands)

12 Mos. 9/30/26

12 Mos. 9/30/25

Cash flow provided by operating activities, as reported

$94,232

$97,330

Purchase of property and equipment

(106,429)

(41,978)

Capitalized costs for intangible assets

(6,514)

-

Free cash flow, non-GAAP

$(18,711)

$55,352

Adjustments:

Cash outflow (inflow) for integration-related costs for completed acquisitions(1)

2,672

(304)

Cash outflow for integration-related property, equipment and intangibles

2,113

-

Cash outflow for restructuring costs(2)

1,336

59

Cash outflow for acquisition-related costs(3)

-

873

Adjusted free cash flow, non-GAAP

$(12,590)

$55,980

  1. In fiscal 2025, the Company received $0.7 million in funds in final settlement of the outstanding escrow accounts affiliated with the purchase of Concorde on December 1, 2022. This is offset by additional integration costs incurred during the year.

  2. In May 2026 and July 2026, management approved and implemented phase I and II of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025.

  3. Costs related to both announced and potential acquisition targets.

THANK YOU
Attention: This is an excerpt of the original content. To continue reading it, access the original document here.

Universal Technical Institute Inc on 6ix

In the deck

Earlier from Universal Technical Institute

All Universal Technical Institute news releases